Pharmaceuticals: ViiV Healthcare ranks first in the PatientView ranking

Rome, April 29 (beraking latest news Health) – ViiV Healthcare, a global HIV company with a majority GlaxoSmithKline ranks, for the eighth consecutive year, in first place in the global survey “Corporate Reputation of Pharma – from the Patient Perspective 2020-2021” by PatientView. “The Covid-19 pandemic has made 2020 a year characterized by unique challenges around the world, not only for healthcare but also for the HIV community. However, in the face of a global crisis of this magnitude, which has profoundly impacted on the health and life of people, at ViiV Healthcare we have continued to commit ourselves to our mission: to ensure that no one with HIV is left behind, “reads a statement.

“We are particularly pleased to have been recognized for our continued commitment to the community during this unprecedented period by ranking # 1 in PatientView’s global” Corporate Reputation of Pharma – from the Patient Perspective 2020 – 2021 “survey.

“We will continue to strive – assures the company – to fulfill our ‘promises’ in terms of science, innovation, access to medicines, attention to the most vulnerable people. In ViiV Healthcare, day after day, we work precisely for this, with the aware of being the only company totally dedicated to fighting HIV infection and therefore with a unique DNA, which represents the true heritage of each of us “, concludes the note.